Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from TempraMed Technologies Ltd. ( (TSE:VIVI) ).
TempraMed Technologies Ltd. has announced a strategic agreement with Maccabi Healthcare Services, marking a significant milestone in its global expansion strategy. This partnership allows TempraMed’s flagship products, VIVI Cap and VIVI Epi, to be available through Israel’s second-largest HMO, enhancing the company’s market presence in temperature-sensitive medication management. The collaboration is expected to accelerate access to TempraMed’s life-enhancing technology, supporting its vision to lead the global standard for smart medication protection, and positioning the company for significant growth in the medtech and chronic care markets.
More about TempraMed Technologies Ltd.
TempraMed Technologies Ltd. is a global leader in innovative, temperature-controlled medication storage solutions. The company develops patented, FDA-registered thermal insulation devices that operate without batteries or external power. With products like VIVI Cap and VIVI Epi, TempraMed aims to ensure the effectiveness of life-saving medications and is expanding its operations across North America, Europe, and Asia.
Average Trading Volume: 7,000
Find detailed analytics on VIVI stock on TipRanks’ Stock Analysis page.